Michael J. Yang
CIK 1702283 · View on SEC EDGAR ↗
First SEC filing: June 12, 2026 · Latest: June 12, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 14, 2024 | PCRX | P | 2,000 | $12.90 | $25,800 | 7,230 Direct | +38.24% | Acquired | 90.1% (price as of 2026-08-19) |
| Jan. 6, 2021 | ACAD | S | 1,120 | $53.34 | $59,741 | 8,059 Direct | -12.20% | Disposed | -42.5% (price as of 2026-08-19) |
| Oct. 16, 2020 | ACAD | S | 1,247 | $42.56 | $53,072 | 6,457 Direct | -16.19% | Disposed | -28.0% (price as of 2026-08-19) |
| July 7, 2020 | ACAD | S 10b5-1 | 11,100 | $56.54 | $627,594 | 5,204 Direct | -68.08% | Disposed | -45.8% (price as of 2026-08-19) |
| July 7, 2020 | ACAD | S 10b5-1 | 16,150 | $56.05 | $905,208 | 16,304 Direct | -49.76% | Disposed | -45.3% (price as of 2026-08-19) |
| April 30, 2020 | ACAD | S | 1,501 | $49.21 | $73,864 | 5,204 Direct | -22.39% | Disposed | -37.7% (price as of 2026-08-19) |
| Dec. 12, 2019 | ACAD | S 10b5-1 | 5,032 | $43.74 | $220,100 | 2,499 Direct | -66.82% | Disposed | -29.9% (price as of 2026-08-19) |
| Dec. 12, 2019 | ACAD | S 10b5-1 | 100,447 | $44.49 | $4,468,887 | 7,531 Direct | -93.03% | Disposed | -31.1% (price as of 2026-08-19) |
| Dec. 9, 2019 | ACAD | S 10b5-1 | 3,502 | $50.05 | $175,275 | 1,623 Direct | -68.33% | Disposed | -38.8% (price as of 2026-08-19) |
| Dec. 9, 2019 | ACAD | S 10b5-1 | 11,019 | $50.60 | $557,561 | 5,125 Direct | -68.25% | Disposed | -39.4% (price as of 2026-08-19) |
| Oct. 15, 2019 | ACAD | S | 877 | $39.65 | $34,773 | 1,623 Direct | -35.08% | Disposed | -22.7% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 1, 2026 | IONS | Restricted Stock Unit | Common Stock (2,301) | — | — | 2,301 | Acquired |
| July 1, 2026 | IONS | Non-Qualified Stock Option (right to buy) | Common Stock (5,369) | $79.19 | June 30, 2036 | 5,369 | Acquired |
| June 10, 2026 | PCRX | Stock Option (Right to Buy) | Common Stock (10,891) | $23.42 | June 10, 2036 | 10,891 | Acquired |
| Jan. 15, 2026 | IONS | Restricted Stock Unit | Common Stock (1,930) | — | — | 1,930 | Disposed |
| July 15, 2025 | IONS | Restricted Stock Unit | Common Stock (4,079) | — | — | 4,079 | Disposed |
| July 1, 2025 | IONS | Restricted Stock Unit | Common Stock (5,220) | — | — | 5,220 | Acquired |
| July 1, 2025 | IONS | Non-Qualified Stock Option (right to buy) | Common Stock (11,518) | $39.94 | June 30, 2035 | 11,518 | Acquired |
| June 11, 2025 | PCRX | Stock Option (Right to Buy) | Common Stock (11,279) | $24.34 | June 11, 2035 | 11,279 | Acquired |
| Jan. 15, 2025 | IONS | Restricted Stock Unit | Common Stock (1,931) | — | — | 1,931 | Disposed |
| July 1, 2024 | IONS | Restricted Stock Unit | Common Stock (4,079) | — | — | 4,079 | Acquired |
| July 1, 2024 | IONS | Non-Qualified Stock Option (right to buy) | Common Stock (10,111) | $47.11 | June 30, 2034 | 10,111 | Acquired |
| June 12, 2024 | PCRX | Stock Option (Right to Buy) | Common Stock (12,179) | $28.68 | June 12, 2034 | 12,179 | Acquired |
| Jan. 15, 2024 | IONS | Restricted Stock Unit | Common Stock (5,791) | — | — | 5,791 | Acquired |
| Dec. 14, 2023 | IONS | Non-Qualified Stock Option (right to buy) | Common Stock (12,356) | $49.82 | Dec. 14, 2033 | 12,356 | Acquired |
| Oct. 6, 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (30,967) | $29.80 | Oct. 6, 2033 | 30,967 | Acquired |
| Jan. 6, 2021 | ACAD | Restricted Stock Units | Common Stock (2,722) | — | — | 2,722 | Disposed |
| Oct. 15, 2020 | ACAD | Restricted Stock Units | Common Stock (2,500) | — | — | 2,500 | Disposed |
| July 7, 2020 | ACAD | Stock Option (Right to Buy) | Common Stock (14,750) | $25.12 | April 29, 2029 | 14,750 | Disposed |
| July 7, 2020 | ACAD | Stock Option (Right to Buy) | Common Stock (5,000) | $21.28 | Oct. 14, 2028 | 5,000 | Disposed |
| July 7, 2020 | ACAD | Stock Option (Right to Buy) | Common Stock (7,500) | $19.98 | April 17, 2028 | 7,500 | Disposed |
| April 29, 2020 | ACAD | Restricted Stock Units | Common Stock (4,206) | — | — | 4,206 | Disposed |
| Jan. 6, 2020 | ACAD | Restricted Stock Units | Common Stock (10,889) | — | — | 10,889 | Acquired |
| Jan. 6, 2020 | ACAD | Stock Options (Right to Buy) | Common Stock (39,516) | $42.81 | Jan. 6, 2030 | 39,516 | Acquired |
| Dec. 12, 2019 | ACAD | Stock Option (Right to Buy) | Common Stock (72,979) | $35.86 | March 28, 2027 | 72,979 | Disposed |
| Dec. 12, 2019 | ACAD | Stock Option (Right to Buy) | Common Stock (10,000) | $21.28 | Oct. 14, 2028 | 10,000 | Disposed |
| Dec. 12, 2019 | ACAD | Stock Option (Right to Buy) | Common Stock (22,500) | $19.98 | April 17, 2028 | 22,500 | Disposed |
| Dec. 9, 2019 | ACAD | Stock Option (Right to Buy) | Common Stock (14,521) | $35.86 | March 28, 2027 | 14,521 | Disposed |
| Oct. 15, 2019 | ACAD | Restricted Stock Units | Common Stock (2,500) | — | — | 2,500 | Disposed |
| April 29, 2019 | ACAD | Restricted Stock Units | Common Stock (16,827) | — | — | 16,827 | Acquired |
| April 29, 2019 | ACAD | Stock Options (Right to Buy) | Common Stock (59,042) | $25.12 | April 29, 2029 | 59,042 | Acquired |
| Oct. 15, 2018 | ACAD | Restricted Stock Units | Common Stock (10,000) | — | — | 10,000 | Acquired |
| Oct. 15, 2018 | ACAD | Stock Option (right to buy) | Common Stock (40,000) | $21.28 | Oct. 15, 2028 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $516,805 | — | $932,316 | $935,316 | $210,921 | — | $25,321 | $2,620,679 |
| 2019 | $500,701 | — | $1,291,323 | $842,087 | $287,328 | — | $22,383 | $2,943,821 |
| 2018 | $485,250 | — | $212,800 | $2,077,607 | $237,773 | — | $169,480 | $3,182,910 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.